Source link : https://www.newshealth.biz/health-news/depression-trial-wins-losses-americans-chronic-insomnia-kids-sleep-anxiety/
Another phase III trial of lumateperone as adjunctive therapy in patients with major depressive disorder met its endpoints, significantly reducing Montgomery-Åsberg Depression Rating Scale (MADRS) scores by week 6, said Intra-Cellular Therapies. In other news, investigational esmethadone — one of the two components of methadone — flopped in a late-stage trial as adjunctive treatment in […]
Author : News Health
Publish date : 2024-06-19 17:00:00
Copyright for syndicated content belongs to the linked Source.
Categories